Skip to search
Skip to main content
Back to Search
Start Over
Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data
Authors :
Kimyon, G. Kalyoncu, U. Kiraz, S. Bes, C. Coskun, N. Yagiz, B. Kucuksahin, O. Kanitez, N. Erden, A. Kilic, L. Bilgin, E. Kasifoglu, T. Emmungil, H. Koca, S. S. Akar, S. Cinar, M. Yazisiz, V. Ates, A. Ersozlu, D. Gonullu, E. Mercan, R. Ertenli, I. Omer Karadag Bolek, E. C. Farisogullari, B. Yakkan, G. Sari, A. Armagan, B. Dalkilic, E. Pehlivan, Y. Erten, S. Bilge, S. Y. Ilgen, U. Karatas, A. Yilmaz, S. Tekgoz, E. Colak, S. Terzioglu, E. Kelesoglu, B.
Source :
Scopus-Elsevier
Details
Database :
OpenAIRE
Journal :
Scopus-Elsevier
Accession number :
edsair.dedup.wf.001..3285a0ab20f65af661399180b7b64784